HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 292/1/E117    most recent 00642.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (8) Citing Articles via Google Scholar Google Scholar Articles by Cornish, J. Articles by Reid, I. R. Search for Related Content PubMed PubMed Citation Articles by Cornish, J. Articles by Reid, I. R.

Preptin, another peptide product of the pancreatic -cell, is osteogenic in vitro and in vivo

¹Department of Medicine and ²School of Biological Sciences, University of Auckland, Auckland, New Zealand

Submitted 20 December 2005 ; accepted in final form 7 August 2006

Several hormones that regulate nutritional status also impact on bone metabolism. Preptin is a recently isolated 34-amino acid peptide hormone that is cosecreted with insulin and amylin from the pancreatic -cells. Preptin corresponds to Asp⁶⁹-Leu¹⁰² of pro-IGF-II. Increased circulating levels of a pro-IGF-II peptide complexed with IGF-binding protein-2 have been implicated in the high bone mass phenotype observed in patients with chronic hepatitis C infection. We have assessed preptin's activities on bone. Preptin dose-dependently stimulated the proliferation (cell number and DNA synthesis) of primary fetal rat osteoblasts and osteoblast-like cell lines at periphysiological concentrations (>10^–11 M). In addition, thymidine incorporation was stimulated in murine neonatal calvarial organ culture, likely reflecting the proliferation of cells from the osteoblast lineage. Preptin did not affect bone resorption in this model. Preptin induced phosphorylation of p42/p44 MAP kinases in osteoblastic cells in a dose-dependent manner (10^–8-10^–10 M), and its proliferative effects on primary osteoblasts were blocked by MAP kinase kinase inhibitors. Preptin also reduced osteoblast apoptosis induced by serum deprivation, reducing the number of apoptotic cells by >20%. In vivo administration of preptin increased bone area and mineralizing surface in adult mice. These data demonstrate that preptin, which is cosecreted from the pancreatic -cell with amylin and insulin, is anabolic to bone and may contribute to the preservation of bone mass observed in hyperinsulinemic states such as obesity.

osteoblast; bone-active hormone; bone anabolic

This article has been cited by other articles:

				J. Cornish, J. L. Costa, and D. Naot The Bone-Fat Mass Relationship: Laboratory Studies IBMS BoneKEy, September 1, 2009; 6(9): 311 - 322. [Abstract] [Full Text] [PDF]

				J.-M. Lin, K. E. Callon, J.-S. Lin, M. Watson, V. Empson, P. C. Tong, A. Grey, D. Naot, C. R. Green, I. R. Reid, et al. Actions of fibroblast growth factor-8 in bone cells in vitro Am J Physiol Endocrinol Metab, July 1, 2009; 297(1): E142 - E150. [Abstract] [Full Text] [PDF]